PARP1 and neoplasm: The above-combined strategies show that PARP-1 inhibitors have a strong potential for the treatment of tumours, and the development of a new generation of PARP-1 inhibitors with high selectivity or brain penetration is helpful to make better use of its therapeutic potential.